Three-Dimensional Amide Proton Transfer MR Imaging of Gliomas: current status and future options

Three-Dimensional Amide Proton Transfer (3D APT) is a unique, contrast-free, brain MR imaging method addressing the need for more confident diagnosis in neuro oncology. 3D APT uses the presence of endogenous cellular proteins to produce an MR signal that directly correlates with cell proliferation, a marker of tumor activity. 3D APT supports medical professionals in differentiating low from high grade gliomas, and tumor progression from treatment effect.

In this webinar Dr Stephane Breil will address:

  • What APT is and how APT images are generated by an MRI system
  • Current 3D APT clinical applications
  • Potential future of 3D APT applications

After the lecture, a 15-minute question and answer session will follow. All participants are welcomed and encouraged to share in the dialogue.

Course information


Dr Anna Lerman, MD, Dr Stephane Breil, PhD






Registration Closed

Registration Fee



Radiologists, Radiographers

Seats Available


Download Course Flyer


This webinar will be presented in a lecture format with Q&A session at the end.

Following registration via this site, registrants will receive an email with the access details nearer to event date. 

Duration: 12:30 pm – 1:30 pm SGT (UTC+8)


12:25 pm - 12:30 pm Login to the webinar
12:30 pm - 12:35 pm Welcome by Anna Lerman
12:35 pm - 01:00 pm Lecture by Stephane Breil
01:00 pm - 01:15 pm Q&A and closure

About speaker

Dr Anna Lerman, MD

Business Marketing Manager, MRI, APAC, Philips

Dr Anna Lerman has previous experience as a radiologist working in the field of General Diagnostic and Cardiac Imaging in leading scientific institution hospitals in Moscow, Russia. She is currently managing MR business in ASEAN Pacific region.

Dr Stephane Breil, PhD

MRI Clinical Specialist, Philips

Dr Stephane Breil attained his PhD in NMR Spectroscopy, from the Paul Sabatier University, Toulouse, France. He has 20 years of experience in MRI Advanced Applications.